Form 8-K Sunshine Biopharma Inc. For: Jul 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St futures ease as Big Tech earnings rekindle AI spending worries, oil jumps
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Dollar hits fresh 40-year high versus yen, edges higher against euro
Sunshine Biopharma sets up $4M at-the-market stock offering
July 20, 2026 4:28 PM EDTSunshine Biopharma, Inc. (NASDAQ: SBFM) entered into an at-the-market issuance sales agreement with Aegis Capital Corp. on July 20, 2026, allowing the company to sell up to $4,000,000 in common stock through the arrangement.
Under the agreement, Aegis Capital will act as exclusive sales agent,... More
